What Are Peptides? A Clear Guide to Types, How They Work, and Uses

What are peptides in simple terms?

Peptides are short strings of amino acids, the same building blocks that make proteins. The difference is length. A commonly used scientific cutoff calls a chain of roughly 2 to 50 amino acids a peptide, and anything longer a polypeptide or a protein (MedlinePlus, U.S. National Library of Medicine). Two amino acids joined together make a dipeptide, three make a tripeptide, and so on up the chain.

Each link is a peptide bond, formed when the carboxyl group of one amino acid reacts with the amino group of the next. That bond gives the molecule a stable backbone, and the order of the amino acids gives it a specific shape. Shape matters, because shape is what lets a peptide fit a receptor.

Your body makes thousands of its own peptides. Insulin is a peptide hormone. So is glucagon, so are many gut hormones, and so are neuropeptides that carry messages in the brain. The peptides discussed in research settings are usually synthetic versions of natural signals, or close analogs designed to last longer or bind more selectively.

How do peptides work in the body?

Most studied peptides work as signaling molecules. A peptide binds to a receptor on or inside a cell, and that binding starts a chain of events, more of one protein, less of another, a shift in metabolism, or a repair response. Peptides are broadly used for cell-to-cell communication across living things, including a large group of peptide hormones, growth factors, and neuropeptides in animals.

A few concrete examples make the pattern clear:

- Growth-hormone-releasing hormone (GHRH) is a peptide. Analogs of it bind GHRH receptors on the pituitary and prompt the gland to release its own growth hormone in pulses. CJC-1295 is one such analog; a 2006 trial reported that a single dose raised mean growth hormone about 2 to 10 fold and IGF-1 about 1.5 to 3 fold in healthy adults (Teichman et al., JCEM 2006;91(3):799-805). - GLP-1 is a gut peptide that signals fullness and helps control blood sugar. Drugs that mimic or extend it, and newer molecules that hit two or three receptors at once, drive the metabolic peptide class covered below. - The copper tripeptide GHK binds copper ions and appears to influence collagen and repair gene programs in skin (Pickart and Margolina, Int J Mol Sci 2018;19(7):1987).

The takeaway: a peptide is a message, not a bulk material. Because the body reads these messages through specific receptors, small differences in sequence can change what a peptide does. Most peptides are also given by injection in research settings, because the digestive tract would break many of them down before they reached the bloodstream. Insulin is the classic example of that limitation.

What are the main classes of peptides?

Below are the major groups people study today, each with a real reference. Compound names link to deeper pages where they exist.

### Growth-hormone secretagogues (GH peptides)

These peptides nudge the body to release its own growth hormone rather than adding growth hormone directly. Two mechanisms show up. GHRH analogs like CJC-1295 and tesamorelin act on the GHRH receptor. Ghrelin-mimetic secretagogues like ipamorelin act on a different receptor and can raise growth hormone with little effect on cortisol or prolactin (Raun et al., Eur J Endocrinol 1998;139(5):552-561). Tesamorelin is the one FDA-approved member of this family; a 2007 trial reported visceral fat fell about 15.2% versus a 5.0% rise on placebo in the studied population (Falutz et al., NEJM 2007;357:2359-2370). See [CJC-1295 and ipamorelin](/cjc-ipamorelin) and [tesamorelin](/tesamorelin).

### GLP-1 and metabolic peptides

This is the most clinically validated class. GLP-1 receptor agonists and the newer dual and triple agonists change appetite and blood sugar signaling. Semaglutide, a GLP-1 agonist, produced a mean weight change of about -15.3 kg versus -2.6 kg on placebo over 68 weeks in a large trial (Wilding et al., NEJM 2021;384:989-1002). Tirzepatide, a GIP plus GLP-1 dual agonist, reported up to about 22.5% mean weight reduction over 72 weeks (Jastreboff et al., NEJM 2022;387:205-216). Retatrutide, an investigational triple agonist (GLP-1, GIP, and glucagon), reported a mean weight change up to about 24.2% at 48 weeks in a phase 2 trial (Jastreboff et al., NEJM 2023; doi:10.1056/NEJMoa2301972). See [retatrutide](/retatrutide), [tirzepatide](/tirzepatide), and [peptides for weight loss](/peptides-for-weight-loss).

### Healing and repair peptides

These are studied for tissue repair, mostly in animal models so far. BPC-157, a synthetic pentadecapeptide, has been reported to promote angiogenesis and tendon and muscle healing through pathways including VEGFR2 and nitric oxide signaling, though human data remain very limited (Sikiric et al., review, PMC7096228). TB-500 is a fragment tied to thymosin beta-4, whose actin-binding motif has been shown to promote new blood vessel formation (Philp et al., FASEB J 2003;17(14):2103-5). See [BPC-157](/bpc-157), [TB-500](/tb-500), and [peptides for recovery](/peptides-for-recovery).

### Cosmetic and copper peptides

Copper peptides are studied for skin. GHK is a natural tripeptide that binds copper, and the GHK-Cu complex has been reported to increase collagen, elastin, and glycosaminoglycan synthesis and to support wound healing in animal studies (Pickart and Margolina, Int J Mol Sci 2018;19(7):1987). The same review notes plasma GHK declines with age, from roughly 200 ng/mL near age 20 to about 80 ng/mL by age 60. See [GHK-Cu](/ghk-cu) and [copper peptides](/copper-peptides).

### Mitochondrial peptides

A newer group encoded within mitochondrial DNA. MOTS-c is a 16-amino-acid mitochondrial-derived peptide that activates AMPK, a master energy sensor; in mice it prevented high-fat-diet weight gain and insulin resistance (Lee et al., Cell Metab 2015;21(3):443-454). Human evidence is early. See [MOTS-c](/mots-c).

### Sexual-health peptides

At least one peptide in this space is FDA-approved. Bremelanotide (PT-141), an MC4R agonist, met its desire and distress endpoints in phase 3 trials of premenopausal women and was approved in 2019; the most common adverse event was nausea, in about 40% of participants (Kingsberg et al., Obstet Gynecol 2019;134:899-908).

What does research report peptides are used for?

Uses fall out of the classes above. In clinical and research settings, peptides are studied for metabolic conditions and body composition (the GLP-1 class, with the strongest human data), for stimulating the body's own growth hormone (the secretagogue class), for tissue repair (the healing class, mostly animal models), for skin (copper peptides), and for specific approved indications like HIV-associated lipodystrophy (tesamorelin) and premenopausal HSDD (bremelanotide).

It is worth separating the tiers. Semaglutide, tirzepatide, tesamorelin, and bremelanotide are FDA-approved for specific uses. Retatrutide is investigational. Many others, including most healing and mitochondrial peptides, rest largely on animal data or small pilot studies. Depth of evidence is not equal across the field, and a real citation is the fastest way to see where a given peptide sits.

Are peptides safe? A balanced overview

Safety depends entirely on the specific peptide, the dose studied, and the context. There is no single answer for "peptides" as a category, any more than there is one for "medicines."

Some data points from the record: bremelanotide's most common adverse event in trials was nausea, in about 40% of participants (Kingsberg et al., Obstet Gynecol 2019). GLP-1-class agents commonly report gastrointestinal effects such as nausea in their trials. Growth-hormone secretagogues raise IGF-1, and one long-term study of an oral ghrelin mimetic reported that fasting glucose rose and insulin sensitivity fell (Nass et al., Ann Intern Med 2008;149(9):601-611), a reminder that boosting a growth pathway is not free of metabolic tradeoffs.

Two broader cautions apply across the field. First, many research peptides have thin or no human safety data; a strong animal result is not a human safety guarantee. Second, product quality varies, so purity and identity testing (a certificate of analysis) matter for anything used in research. For a fuller treatment, see [peptide side effects](/peptide-side-effects) and [certificate of analysis](/coa). For the legal picture, see [are peptides legal](/are-peptides-legal).

This section is educational. It is not medical advice, and nothing here is a recommendation to use any peptide.

What does research report about peptide dosing?

The ranges below reflect what published studies and commonly studied research protocols report. This is educational, not a prescription or a personal recommendation. Doses are shown in the units each source used. They describe what a trial administered, not what any reader should do.

A note on unit math, offered only as a generic reference: research peptides are often measured in milligrams, while insulin-style syringes are marked in "units," where 100 units equals 1 mL. So the volume drawn depends on how a vial was reconstituted, that is, how much liquid was added. The arithmetic (concentration equals total mg divided by mL added) is the same regardless of peptide. See [reconstitution](/reconstitution) for the general method.

Common misconceptions about peptides

**"Peptides and proteins are different things."** They are the same chemistry, amino acids joined by peptide bonds. The label changes with length, around the 50-amino-acid mark (MedlinePlus). Insulin is small enough to be called a peptide; a large enzyme is a protein.

**"Peptides are all natural and therefore all safe."** Being peptide-shaped says nothing about safety. Some peptides are approved drugs with known side-effect profiles; many others have little human data at all. See [peptide side effects](/peptide-side-effects).

**"Collagen peptides you drink build skin collagen directly."** Ingested collagen is broken down into amino acids and small fragments during digestion. Any effect works through supplying building blocks and possible signaling fragments, not by the drink arriving intact at the skin. That is a different mechanism from a receptor-targeted signaling peptide.

**"One peptide does one thing."** Many peptides are pleiotropic, meaning they touch several pathways. GHK, for example, is reported to affect a wide set of repair-related genes, not a single switch (Pickart and Margolina, Int J Mol Sci 2018).

**"If it worked in mice, it works in people."** A large share of peptide claims rest on animal studies. Human results can differ in size, direction, or safety. The presence or absence of a human trial is the detail that matters most.

Where to go next

Start with a class hub, then a specific compound. For fat loss and metabolic peptides, see [peptides for weight loss](/peptides-for-weight-loss) and [peptides for fat loss](/peptides-for-fat-loss). For repair, see [peptides for recovery](/peptides-for-recovery). For lean mass, see [peptides for muscle growth](/peptides-for-muscle-growth). For definitions of individual terms, see the [peptide glossary](/peptide-glossary).

FAQ

**What are peptides in simple words?** Peptides are short chains of amino acids, usually about 2 to 50, joined by peptide bonds. Many act as signaling molecules that bind receptors and tell cells what to do, which is why peptides sit behind hormones like insulin and many growth factors (MedlinePlus).

**What is the difference between a peptide and a protein?** Length. A chain of roughly 2 to 50 amino acids is usually called a peptide, and longer chains are called polypeptides or proteins (MedlinePlus). The chemistry, amino acids linked by peptide bonds, is the same.

**How do peptides work?** Most studied peptides act as signals. A peptide binds a specific receptor and starts a response inside the cell, such as releasing a hormone or changing metabolism. For example, CJC-1295 binds GHRH receptors and prompted the pituitary to release growth hormone in a 2006 trial (Teichman et al., JCEM 2006).

**Are peptides safe?** It depends on the specific peptide, dose, and context. Some are FDA-approved with known side-effect profiles; many others have little human safety data. GLP-1-class agents commonly report gastrointestinal effects, and bremelanotide reported nausea in about 40% of trial participants (Kingsberg et al., Obstet Gynecol 2019). See [peptide side effects](/peptide-side-effects).

**Why are most research peptides injected instead of taken by mouth?** The digestive tract breaks down many peptides before they reach the bloodstream. Insulin is the classic example: it is a peptide that cannot be swallowed effectively and is given by injection. Some peptides, like the oral secretagogue MK-677, are exceptions studied in pill form (Nass et al., Ann Intern Med 2008).

**Which peptides have the strongest human evidence?** The GLP-1 metabolic class. Semaglutide and tirzepatide are FDA-approved with large phase 3 trials (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). Tesamorelin and bremelanotide are also approved for specific uses. Many other peptides rest mainly on animal data.

**Do collagen peptide supplements build skin collagen directly?** Not directly. Ingested collagen is digested into amino acids and small fragments, so any benefit comes from supplying building blocks, not from the peptide arriving intact at the skin. That differs from a receptor-targeted signaling peptide.

**What are the main classes of peptides?** Common groups include growth-hormone secretagogues (CJC-1295, ipamorelin, tesamorelin), GLP-1 and metabolic peptides (semaglutide, tirzepatide, retatrutide), healing peptides (BPC-157, TB-500), copper and cosmetic peptides (GHK-Cu), and mitochondrial peptides (MOTS-c).